Product Introduction:
Dycizol Tablet contains Dotinurad, a selective urate reabsorption inhibitor (SURI) that works by inhibiting the URAT1 transporter in the kidneys, leading to increased excretion of uric acid through urine. It is used primarily for the management of hyperuricemia in CKD patients who are at risk of complications like gout, nephrolithiasis (kidney stones), and urate nephropathy.
Uses:
-
Hyperuricemia in chronic kidney disease
-
Prevention of gout in CKD patients
-
Management of uric acid-related kidney damage
Benefits:
-
Reduces serum uric acid levels effectively
-
Well tolerated in CKD patients
-
Can be used where other uric acid-lowering agents are not suitable
-
Lowers risk of uric acid crystal deposition and related complications
Composition:
Each tablet contains:
-
Dotinurad 1 mg / 2 mg (verify with pack – available in both strengths)
Side Effects:
-
Headache
-
Increased uric acid in urine (uricosuria)
-
Elevated liver enzymes (rare)
-
Gastrointestinal discomfort
-
Rash or allergic reaction (rare)
Safety Advice:
-
Take once daily, preferably after meals
-
Drink plenty of water to reduce risk of kidney stones
-
Monitor uric acid levels regularly
-
Use with caution in liver impairment
-
Not recommended during pregnancy or breastfeeding unless advised by doctor
-
Store in a cool, dry place
-
Keep out of reach of children
